COVID-19 resurgence in Asia: What you need to know about the JN.1 variant
The COVID-19 pandemic continues to evolve, with the emergence of new variants posing fresh challenges to global health. One such variant, JN.1, has recently been identified and is contributing to a resurgence of cases in various regions, particularly in Asia.Understanding the characteristics of JN.1, its impact, and the recommended precautions is crucial in navigating this phase of the pandemic.advertisementEMERGENCE AND SPREADThe JN.1 variant, a sub-lineage of the BA.2.86 strain, was first detected in the United States in September 2023. Since then, it has been reported in multiple countries, including China, Indonesia, the Philippines, Malaysia, and Singapore.In Singapore, the Ministry of Health reported a significant increase in COVID-19 cases, with the majority attributed to the JN.1 variant. The estimated number of cases rose to 56,043 between December 3 and 9, marking a 75 per cent increase compared to the previous week.In India, the first case of JN.1 was reported in Kerala. As of January 18, 2024, a total of 1,226 cases have been detected across 17 states and Union Territories. Karnataka and Andhra Pradesh recorded the highest numbers, with 234 and 189 cases respectively.CHARACTERISTICSThe World Health Organisation (WHO) has classified JN.1 as a 'variant of interest' due to its rapidly increasing spread. However, current evidence suggests that JN.1 does not pose a higher global public health risk compared to other circulating variants.advertisementThe symptoms associated with JN.1 are similar to those of previous COVID-19 strains, including fever, cough, fatigue, and sore throat. There is no indication that JN.1 causes more severe illnesses.IMPACT ON HEALTHCARE SYSTEMThe surge in JN.1 cases has led to increased hospitalisations in affected regions. In Singapore, average daily COVID-19 hospitalisations rose from 225 to 350, with intensive care unit cases increasing from four to nine during the same period.Despite the rise in cases, the majority of patients have experienced mild symptoms, with many opting for home isolation. Health authorities continue to monitor the situation closely to manage healthcare resources effectively.PRECAUTIONSHealth authorities recommend the following measures to mitigate the spread of JN.1:Vaccination: Stay updated with COVID-19 vaccinations, including booster doses, to enhance protection against emerging variants.Mask-wearing: Wear masks in crowded and poorly ventilated spaces, especially when visiting vulnerable individuals.Hygiene practices: Maintain regular handwashing and use hand sanitisers to reduce the risk of infection.Social responsibility: Individuals experiencing symptoms of acute respiratory infection should stay at home and avoid contact with others to prevent transmission.While the emergence of the JN.1 variant has led to an uptick in COVID-19 cases in certain regions, current data does not indicate an increased severity compared to previous variants.Continued adherence to public health guidelines and preventive measures remains essential in managing the impact of JN.1 and safeguarding public health.Must Watch
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News18
23 minutes ago
- News18
IP University To Launch Orphan Children Quota With 100% Fee Waiver From 2025-26 Session
Last Updated: Guru Gobind Singh IPU will introduce a special orphan quota in its programmes, adding to last year's Single Girl Child quota. Guru Gobind Singh Indraprastha University (IPU) has decided to introduce a special quota for orphan children across its various programmes, adding to the Single Girl Child quota that was implemented last year. The university's Academic Council has approved this new quota, which will take effect from the 2025-26 academic session. Under the scheme, one extra seat will be reserved in each of the university's schools and programmes specifically for orphaned students. Those admitted under this quota will also receive a full fee waiver under the university's EWS (Economically Weaker Section) scheme, as reported by news agency PTI. Padma Shri Prof (Dr) Mahesh Verma, the Vice Chancellor of IPU, stated that the university is committed to providing access to quality education for all, including orphan children who have lost their parents due to the COVID-19 pandemic or other circumstances. The university also plans to assist these students by helping them secure financial support through various government welfare schemes. With this move, IP University will be among the first universities in India to implement such a quota. Detailed guidelines and eligibility criteria will soon be published on the university's official website. During the Academic Council meeting, several other academic changes and additions were also discussed. Among these is the introduction of a dedicated PhD programme for working professionals, allowing them to pursue research degrees while continuing their careers. The council has also approved lateral entry for the MBA programme in Fire and Industrial Safety, providing more flexibility for candidates with relevant qualifications. In addition, the university plans to expand its foreign language offerings by adding certificate courses in Spanish and other widely spoken international languages. New academic programmes will include a five-year integrated BA-MA course in Philosophy and four-year BEd Special Education programmes in three additional disciplines. A Post-MSc Diploma in Radiological Physics will also be introduced to cater to the growing demand in the healthcare sector. To further promote Indian heritage and innovation, the university will set up an 'In-Situ Centre for Indian Knowledge System and Technology Innovation," which will focus on preserving and promoting India's traditional knowledge systems and technological advancements. Meanwhile, the Narela campus of IP University will soon become operational with new programmes like MSc in Microbiology, along with several certificate and diploma courses, adding to the university's expanding academic infrastructure. First Published: June 13, 2025, 18:39 IST
Time of India
38 minutes ago
- Time of India
Your Covid vaccination might save your kidneys, reveals UCLA study
A new study from UCLA Health has found that being vaccinated against Covid-19 may significantly lower the risk of severe kidney damage among hospitalized patients. The research, which analyzed data from approximately 3,500 patients admitted between March 2020 and March 2022, revealed that those who had been vaccinated were considerably less likely to require continuous renal replacement therapy (CRRT)—a form of dialysis used in intensive care settings—compared to their unvaccinated counterparts. According to the findings, unvaccinated Covid patients were 16% more likely to need CRRT during their hospital stay and more than two-and-a-half times as likely to require it after discharge. Additionally, unvaccinated patients faced a higher risk of death following discharge. CRRT, often used in critical care units, helps perform the essential functions of damaged kidneys by continuously filtering waste from the blood. Lead author Dr. Niloofar Nobakht, a nephrology professor at UCLA, explained that this nonstop dialysis is vital for patients in intensive care whose kidneys can no longer function properly. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Neuropathy & Nerve Damage? Do This Immediately Health Journal Britain Learn More Undo The study defined vaccinated individuals as those who had received at least two doses of the Pfizer or Moderna mRNA vaccines, or one dose of the Johnson & Johnson Janssen vaccine. Its goal was to assess the severity of kidney injury in Covid patients requiring CRRT during and after hospitalization. However, some experts caution against overinterpreting the results due to a major limitation: the study lacked data on the patients' baseline kidney health prior to infection. Dr. Scott Roberts, associate medical director of infection prevention at Yale School of Medicine, told NBC News that it's unclear how well the kidneys were functioning before Covid, making it difficult to fully determine how much of the benefit was due to vaccination alone. He also explained that Covid can damage the kidneys directly or indirectly—through harm to other organs such as the lungs or heart—with disease severity being the main factor in kidney injury. Live Events Yong Chen, a biostatistics professor at the University of Pennsylvania, added that serious kidney complications are typically associated with severe Covid cases and are rare among those with mild or asymptomatic infections. He emphasized that the risk of post-Covid kidney complications is especially high for older adults and people with weakened immune systems. A nephrologist at Yale University, Dr. F. Perry Wilson told NBC that the primary reason vaccinated individuals have lower kidney injury rates is because they tend to experience less severe illness. He pointed out that while vaccines don't directly protect kidney cells, they reduce the severity of disease, which in turn helps prevent systemic complications like multi-organ failure. Some medical professionals also raised concerns about individuals with glomerulonephritis, a kidney condition affecting the organ's filtering units. Dr. Jeffrey S. Berns, a nephrologist at the University of Pennsylvania, told NBC that reports of both adults and children experiencing relapses or new onset of glomerulonephritis after Covid infection and, in some cases, following vaccination. Although he was not involved in the UCLA study, Berns urged caution for this subset of patients. While the research focused on adults, children may also face kidney risks from Covid. Chen highlighted findings from his team's separate study showing that children with prior Covid infections had a 35% higher risk of developing new chronic kidney disease within six months.
The Hindu
an hour ago
- The Hindu
Watch: On good and bad bacteria, why micronutrients in food matter, and more
Ramya Kannan and Zubeda Hamid break down top health stories -- from Europe's biggest diphtheria outbreak in decades and nanoplastics worsening infections, to heat-loving bacteria that may fight antibiotic resistance. Plus, why micronutrients in food matter, how climate change is affecting our health, and a mental health check-in for India's overworked youth. Catch expert insights from Dr. V. Mohan on GLP-1 receptor agonists and how they're revolutionising diabetes and obesity care. Videography: Thamodharan B. Editing: Athira Ellsa Johnson and Thamodharan B.
